A Pilot Study of Flaxseed vs. Aromatase Inhibitors Between Biopsy and Surgery: Breast Tumor Characteristics and Prognosis.

Trial Profile

A Pilot Study of Flaxseed vs. Aromatase Inhibitors Between Biopsy and Surgery: Breast Tumor Characteristics and Prognosis.

Completed
Phase of Trial: Phase 0

Latest Information Update: 18 Aug 2017

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Early breast cancer
  • Focus Pharmacodynamics
  • Acronyms FABrC
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 07 May 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 07 May 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top